96 related articles for article (PubMed ID: 23421110)
1. Thyroid associated orbitopathy--medication, radioiodine or operation?
Czarnywojtek A; Zgorzalewicz-Stachowiak M; Stangierski A; Florek E; Zdanowska J; Katarzyna H; Andrzejewska M; Ruchała M
Przegl Lek; 2012; 69(10):1140-3. PubMed ID: 23421110
[TBL] [Abstract][Full Text] [Related]
2. Endocrine ophthalmopathy and radioiodine therapy.
Karlsson FA
Acta Oncol; 2006; 45(8):1046-50. PubMed ID: 17118837
[TBL] [Abstract][Full Text] [Related]
3. Do glucocorticoids affect outcome in Graves' disease following radioiodine therapy?
Salvatore D; Fenzi G
Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):194-5. PubMed ID: 16932282
[No Abstract] [Full Text] [Related]
4. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
[TBL] [Abstract][Full Text] [Related]
5. Radioiodine therapy and thyroid-associated orbitopathy: risk factors and preventive effects of glucocorticoids.
Dietlein M; Dederichs B; Weigand A; Schicha H
Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 5():S190-4. PubMed ID: 10614920
[TBL] [Abstract][Full Text] [Related]
6. Grave's Eye disease developing following radioiodine treatment for toxic nodular goitre.
Tahrani AA; Rangan S; Moulik P
Exp Clin Endocrinol Diabetes; 2007 Jul; 115(7):471-3. PubMed ID: 17647147
[TBL] [Abstract][Full Text] [Related]
7. Graves' orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis.
Vannucchi G; Campi I; Covelli D; Dazzi D; Currò N; Simonetta S; Ratiglia R; Beck-Peccoz P; Salvi M
J Clin Endocrinol Metab; 2009 Sep; 94(9):3381-6. PubMed ID: 19567525
[TBL] [Abstract][Full Text] [Related]
8. Oral steroid prophylaxis for Graves' orbitopathy after radioactive iodine treatment for Graves' disease is not only effective, but also safe.
Rosetti S; Tanda ML; Veronesi G; Masiello E; Premoli P; Gallo D; Cusini C; Donati S; Sabatino J; Ippolito S; Piantanida E; Bartalena L
J Endocrinol Invest; 2020 Mar; 43(3):381-383. PubMed ID: 31587179
[No Abstract] [Full Text] [Related]
9. Graves' ophthalmopathy and 131I therapy.
Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
[TBL] [Abstract][Full Text] [Related]
10. [Graves' orbitopathy].
Balázs C
Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
[TBL] [Abstract][Full Text] [Related]
11. [Thyroid associated orbitopathy: from diagnosis to treatment].
Hamédani M; Obéric A
Rev Med Suisse; 2013 Jan; 9(368):66-71. PubMed ID: 23367708
[TBL] [Abstract][Full Text] [Related]
12. Prevention of thyroid associated-ophthalmopathy in children and adults: current views and management of preventable risk factors.
Krassas GE; Perros P
Pediatr Endocrinol Rev; 2007 Mar; 4(3):218-24. PubMed ID: 17551483
[TBL] [Abstract][Full Text] [Related]
13. Clinical practice. Graves' ophthalmopathy.
Bartalena L; Tanda ML
N Engl J Med; 2009 Mar; 360(10):994-1001. PubMed ID: 19264688
[No Abstract] [Full Text] [Related]
14. Influence of biological sex, age and smoking on Graves' orbitopathy - a ten-year tertiary referral center analysis.
Oeverhaus M; Winkler L; Stähr K; Daser A; Bechrakis N; Stöhr M; Chen Y; Eckstein A
Front Endocrinol (Lausanne); 2023; 14():1160172. PubMed ID: 37082130
[TBL] [Abstract][Full Text] [Related]
15. Optimal management of Graves orbitopathy: a multidisciplinary approach.
Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
[TBL] [Abstract][Full Text] [Related]
16. Cigarette smoking and treatment outcomes in Graves ophthalmopathy.
Bartalena L; Marcocci C; Tanda ML; Manetti L; Dell'Unto E; Bartolomei MP; Nardi M; Martino E; Pinchera A
Ann Intern Med; 1998 Oct; 129(8):632-5. PubMed ID: 9786811
[TBL] [Abstract][Full Text] [Related]
17. Prevention of Graves' ophthalmopathy.
Bartalena L
Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):371-9. PubMed ID: 22632372
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
19. [Radioiodine therapy of immune hyperthyroidism depending on age. A tenable risk even for younger patients?].
Becker W; Börner W; Reiners C; Roedler HD
Dtsch Med Wochenschr; 1988 Jun; 113(23):954-61. PubMed ID: 2454185
[No Abstract] [Full Text] [Related]
20. [Radioiodine therapy for Graves' disease: problems and new developments].
Reiners C
Z Arztl Fortbild Qualitatssich; 2004 May; 98 Suppl 5():55-62. PubMed ID: 15255314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
